
Oncology Clinic
The Pediatric Oncology Clinic team of world-renowned childhood cancer experts includes doctors, nurses and social workers, who care for patients with every type of childhood cancer. We understand that undergoing cancer treatment is emotionally difficult, and we offer not just a helping hand, but a hand to hold.
In addition to treating patients, our doctors lead world-class research aimed at advancing the understanding and treatment of cancer. Thanks to that work, patients have the opportunity to participate in large-scale clinical trials of new therapies and drugs. Our goal is to help kids get better as quickly as possible so they can put cancer behind them and get on with their lives.
Our locations (3)
Our team
-
Katherine K. Matthay
MD
Pediatric hematologist-oncologist -
Anurag K. Agrawal
MD
Pediatric hematologist-oncologist -
Anuradha Banerjee
MD, MPH
Pediatric neuro-oncologist -
Barbara Beach
MD
Pediatric hematologist-oncologist -
Benjamin S. Braun
MD
Pediatric hematologist-oncologist -
Christina Coleman
DO
Pediatric hematologist-oncologist and neuro-oncologist -
Robert E. Goldsby
MD
Pediatric hematologist-oncologist -
Carla Golden
MD
Pediatric hematologist-oncologist -
W. Clay Gustafson
MD
Pediatric hematologist-oncologist -
Robert Ward Hagar
MD
Internist -
Caroline Hastings
MD
Hematologist-oncologist and neuro-oncologist -
Michelle L. Hermiston
MD, PhD
Pediatric hematologist-oncologist -
Benjamin J. Huang
MD
Pediatric hematologist and oncologist -
Shannon Kelly
MD
Pediatric hematologist-oncologist -
Nahal Lalefar
MD
Pediatric hematologist-oncologist -
Ashutosh Lal
MD
Pediatric hematologist-oncologist -
Anya Levinson
MD
Pediatric hematologist-oncologist -
Alice Matsunaga
MD
Pediatric hematologist-oncologist -
Jennifer Michlitsch
MD
Pediatric hematologist-oncologist -
Sabine Mueller
MD, PhD
Pediatric neurologist and neuro-oncologist -
Lynne Neumayr
MD
Pediatric hematologist-oncologist -
Cheryl Peretz
MD
Pediatric hematologist-oncologist -
Robert Raphael
MD
Pediatric hematologist-oncologist -
Elizabeth Robbins
MD
Pediatric hematologist-oncologist -
Amit J. Sabnis
MD, MS
Pediatric hematologist-oncologist -
Liz Seashore
MD
Pediatric oncologist -
Kristin A. Shimano
MD
Pediatric hematologist-oncologist -
Sylvia Singer
MD
Pediatric hematologist-oncologist -
Alejandro Sweet-Cordero
MD
Pediatric hematologist-oncologist -
Elliott Vichinsky
MD
Pediatric hematologist-oncologist -
Mark Walters
MD
Pediatric hematologist-oncologist -
Kathryn Aaronson
NP
Nurse practitioner -
Judy Cavazos
PhD
Psychologist -
Carly Hoffman
PNP, MSN
Pediatric nurse practitioner -
Fabienne Hollinger
FNP, MSN
Family nurse practitioner -
Makiko Omori
RD
Dietitian -
Kathleen Praxedes
LCSW
Social worker -
Shannon H. Raber
PNP, MSN
Pediatric nurse practitioner -
Erica Southworth
PNP, MSN
Pediatric nurse practitioner -
Kristen Steglich
LCSW
Social worker -
Ilana C. Withop
NP, MSN
Nurse practitioner
Awards & recognition
-
Best in Northern California for cancer care
-
Ranked among the nation's best in 10 specialties
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
- Completed medical forms that we will mail to you ahead of time
Related clinics (4)

Blood & Marrow Transplant (BMT) Clinic
Support services
Clinical trials
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL...
Power calculations are based on detecting an improvement in post consolidation DFS with the addition of InO to standard therapy for high risk (HR) B-acute lymphoblastic leukemia (ALL). All survival time analyses assume a Weibull d...
Recruiting
More about this studyImatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philad...
Will compare the DFS of standard risk Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL) patients treated continuous imatinib mesylate with high risk Children's Oncology Group (COG)-ALL chemotherapy backbone or more ...
Recruiting
More about this studyA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With...
MRD negative Rem-2 be defined as Rem-2 (i.e., achievement of MRD < 1% blasts by flow cytometry and resolution of extramedullary disease (for CNS disease, requires CNS 1) ) and bone marrow with MRD < 0.01% by flow cytometry. MRD ne...
Recruiting
More about this studyA Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Dia...
Will be assessed in SR-High patients and SR-Avg B-ALL patients who are negative for MRD by flow cytometry but have detectable or indeterminate MRD as measured by high throughput sequencing (HTS) at end of induction (EOI), and pati...
Recruiting
More about this studyFimepinostat in Treating Brain Tumors in Children and Young Adults
Will be analyzed using descriptive statistics from results of fimepinostat concentrations measured within the tumor tissue collected at the time of a standard of care surgery or biopsy. Within each strata, Simon's two-stage design...
Recruiting
More about this studyTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With ...
A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...
Recruiting
More about this studyOur research initiatives
Staff superheroes
It’s a bird. It’s a plane. It’s a window washer! Dressed as a superhero to clean and brighten your day.
